SILVA, M. G. C.; http://lattes.cnpq.br/7628034269601783; SILVA, Michel Giotto Cunha da.
Resumo:
The neuroleptoanalgesia is an interesting technique for chemical restraint due to the
possibility of association of drugs withcharacteristics suitable for the procedures that it
proposes. Therefore, the objective of this study was to evaluate the associations
medetomidine-pethidine-midazolam and tiletamine-zolazepam in female cats undergoing
elective ovariohysterectomy (OSH). It was used 12 female cats divided into two groups: in
the MMP group applied association of medetomidine, midazolam and pethidine(0.04
mg/kg, 0.2 mg/kg and 3mg/kg, respectively), intramuscularly (IM); in the animals of the
TZ group applied the tiletamine/zolazepamassociation (10 mg/kg), also IM. Periods of
Latency, Skillful and recovery were measured, in addition to thesystolic, meanand diastolic
arterial pressures, heart rates (HR) and respiratory rate (f), rectal temperature, degree of
analgesia and muscle relaxation.It was also evaluated the quality of anesthesia care and
chemical restraint.It wasdetermined following times: immediately prior to drug
administration (M0) and every 10 minutes from this (M1, M2, M3, M4 and M5) for 50
minutes.The HR was no significant difference between the moments of TZ group, but the
MMP group was statistically significant progressive decrease in this parameter. The TZ
protocol was able to decrease more quickly and had a greater hipotermizanteeffect when
compared to MMP group. Both protocols induced reductionon blood pressure. The
reasonable and recovery periods were higher in the MMP group. Analgesia was rated as
excellent in all time in both groups. The muscle relaxation was rated excellent at all times
of the MMP group. The quality of recovery from anesthesia and chemical restraint was
rated as excellent in both groups studied. It was concluded that the combination of
medetomidine, midazolam and pethidine promotes excelent chemical restraint, with
intense muscle relaxation and analgesia and more lasting than the one promoted by the
tiletamine-zolazepam association.